Strong research in next-generation sequencing and genomics and an increasing preference for personalised medicine are the primary factors driving the global gene synthesis market to rapid maturity. Gene synthesis is also gaining popularity in molecular diagnosis for the treatment of genetic and infectious diseases as it enables the detection of genetic variations and predicts drug responsiveness.

 

Against this backdrop, personalised medicine, with its patient-centred approach, has gained significant momentum. These factors, coupled with the rising global disease burden, are expected to drive innovation in the gene synthesis sector. Seeing this lucrative business landscape, industry leaders in the gene synthesis industry. are set to engage in next-level collaboration and open innovation to develop more sophisticated, efficient, safe, and reliable techniques for gene synthesis.

 

For More Industry Insight Read : https://www.fairfieldmarketresearch.com/report/gene-synthesis-market

 

Rising Disease Burden Soars Demand for Gene Synthesis Among HCPs & Patients

 

On a global scale, the prevalence of chronic diseases has been consistently rising which is fuelling the demand for new and effective therapies. In this context, healthcare providers (HCP) and patients are considering gene therapy as an optimal method to manage chronic and infectious diseases. Gene therapy can improve the management of endemic and infectious ailments while allowing researchers to understand drug resistance and screen targets for vaccine and therapeutic development. This has attracted researchers to use gene synthetic constructs to accelerate gene therapy, using recombinant DNA technology, single-chain antibodies, and DNA & RNA ribozymes. The cumulative force of these factors is driving the demand for gene synthesis, creating profitable business outcomes in the gene synthesis market

 

Sound Demand for Accurate & Precise Diagnostics Opens New Business Prospects

 

Advancements in gene synthesis or synthetic DNA technology have led to breakthroughs, offering viable and effective solutions to address the rising number of pathogens and associated diseases, such as the COVID-19 virus. The emergence of new strains of Sars-CoV-2 has increased the demand for targeted therapies, driving the adoption of gene synthesis for screening. Research institutions and facilities have also turned to gene synthesis techniques to develop accurate diagnostics for new diseases. This technique efficiently supports medical testing providers in developing reliable and accurate diagnostics for a wide range of conditions. In the coming years, diagnostic procedures are predicted to become more sophisticated and precise, contributing to the expansion of the global gene synthesis market.

 

North America to Sustain Dominance Across Global Gene Synthesis Market

 

The gene synthesis market is expected to see significant growth in North America, with Canada and the United States leading the way. The rising prevalence of chronic and genetic conditions has increased the demand for personalised medicine, creating new opportunities in the region’s gene synthesis market. Moreover, an advanced healthcare infrastructure, government support, rising investments in medical R&D, and strong economic growth are driving growth across North America’s gene synthesis industry. Notably, the Asia Pacific is also emerging as a promising gene synthesis sector due to robust medical innovation and the increasing demand for DNA replication.

 

Leading Market Players

 

Genewiz Inc., Brooks Automation Inc., Merck KGaA, Biomatik, OriGene Technologies Inc., Eurofins Genomics, Integrated DNA Technologies Inc., ProteoGenix, Twist Bioscience, Thermo Fisher Scientific Inc., and GenScript are some of the major players in the gene synthesis market.

 

Get a Sample Copy/TOC of  Gene Synthesis Market : https://www.fairfieldmarketresearch.com/report/gene-synthesis-market/request-toc

 

  • Latest Trending Report :

 

 

 

 

 

 

 

About us

 

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

 

 

Contact

Fairfield Market Research

London, UK

UK +44 (0)20 30025888

USA (Toll-free) +1 (844) 3829746

Web: https://www.fairfieldmarketresearch.com/

Email: sales@fairfieldmarketresearch.com

Follow Us: LinkedIn